ID
17712
Description
Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol; ODM derived from: https://clinicaltrials.gov/show/NCT00549133
Link
https://clinicaltrials.gov/show/NCT00549133
Keywords
Versions (1)
- 9/29/16 9/29/16 -
Uploaded on
September 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hypertension NCT00549133
Eligibility Hypertension NCT00549133
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Congestive heart failure
Data type
boolean
Alias
- UMLS CUI [1]
- C0018802
Description
Azotemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0242528
Description
Diabetes Mellitus, Insulin-Dependent
Data type
boolean
Alias
- UMLS CUI [1]
- C0011854
Description
Hepatic Insufficiency
Data type
boolean
Alias
- UMLS CUI [1]
- C1306571
Description
Pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
Malignant Neoplasms
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
Study Subject Participation Status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Hypertension NCT00549133
- StudyEvent: Eligibility
C0019018 (UMLS CUI [2])
C1969581 (UMLS CUI [2])
C0699749 (UMLS CUI [3])